VOLUME 64 2003 NUMBER 11
Issue to be mailed the week of November 26, 2003
CME Pretest 1281
CME Posttest 1400
Brainstorms
1282 Symptoms and Circuits, Part 1: Major Depressive Disorder.
Stephen M. Stahl
[PDF]
Original Articles
1284 The Relationship Between Postpartum Psychosis and Bipolar
Disorder: A Review. Linda H. Chaudron and Ronald W. Pies
[Abstract]
[PDF]
1293 Cost and Outcome Implications of Using Typical and
Atypical Antipsychotics in Ordinary Practice in Italy. Mauro
Percudani and Corrado Barbui
[Abstract]
[PDF]
1300 Comparison of Clinical Characteristics and Comorbidity in
Schizophrenia Patients With and Without Obsessive-Compulsive
Disorder: Schizophrenic and OC Symptoms in Schizophrenia. [CME] Michael Poyurovsky,
Victoria Kriss, Gregory Weisman, Sarit Faragian, Rena Kurs,
Michael Schneidman, Camil Fuchs, Abraham Weizman, and Ronit
Weizman
[Abstract]
[PDF]
1308 Partial Compliance and Patient Consequences in
Schizophrenia: Our Patients Can Do Better. [CME]
Samuel J. Keith and John M. Kane
[Abstract]
[PDF]
1316 A Prospective, Open-Label, Flexible-Dose Study of
Quetiapine in the Treatment of Delirium. Yukiya Sasaki,
Tetsuaki Matsuyama, Seishiro Inoue, Tomoko Sunami, Takeshi Inoue,
Kenzo Denda, and Tsukasa Koyama
[Abstract]
[PDF]
1322 Escitalopram in the Treatment of Panic Disorder: A
Randomized, Double-Blind, Placebo-Controlled Trial. Stephen M.
Stahl, Ivan Gergel, and Dayong Li
[Abstract]
[PDF]
1328 Lithium Interaction With the Cyclooxygenase 2 Inhibitors
Rofecoxib and Celecoxib and Other Nonsteroidal Anti-Inflammatory
Drugs. Kathleen M. Phelan, Andrew D. Mosholder, and Susan Lu
[Abstract]
[PDF]
1335 Treatment of Bulimia Nervosa With Topiramate in a
Randomized, Double-Blind, Placebo-Controlled Trial, Part 1:
Improvement in Binge and Purge Measures. Scott P. Hoopes,
Frederick W. Reimherr, Dawson W. Hedges, Norman R. Rosenthal,
Marc Kamin, Rezaul Karim, Julie A. Capece, and Debra Karvois
[Abstract]
[PDF]
1342 Risperidone for Severe Tardive Dyskinesia: A 12-Week
Randomized, Double-Blind, Placebo-Controlled Study. Ya-Mei
Bai, Shun-Chieh Yu, and Chao-Cheng Lin
[Abstract]
[PDF]
1349 Long-Term Antidepressant Efficacy and Safety of
Olanzapine/Fluoxetine Combination: A 76-Week Open-Label Study. Sara
A. Corya, Scott W. Andersen, Holland C. Detke, Linda S. Kelly,
Luann E. Van Campen, Todd M. Sanger, Douglas J. Williamson, and
Sanjay Dube
[Abstract]
[PDF]
1357 Psychiatric Comorbidity as a Predictor of Clinical
Response to Nortriptyline in Treatment-Resistant Major Depressive
Disorder. George I. Papakostas, Timothy J. Petersen, Amy H.
Farabaugh, Jessica L. Murakami, Joel A. Pava, Jonathan E. Alpert,
Maurizio Fava, and Andrew A. Nierenberg
[Abstract]
[PDF]
1362 Prolactin Levels During Long-Term Risperidone Treatment
in Children and Adolescents. Robert L. Findling, Vivek
Kusumakar, Denis Daneman, Thomas Moshang, Goedele De Smedt, and
Carin Binder
[Abstract]
[PDF]
1370 The Attribution of Somatization in Schizophrenia
Patients: A Naturalistic Follow-Up Study. Michael Ritsner
[Abstract]
[PDF]
Academic Highlights
1379 New Developments in Antipsychotic Therapy. [CME]
[PDF]
Letters To the Editor
1391 Amitriptyline: Dual-Action Antidepressant? P. Ken
Gillman
[PDF]
- Dr. Thase Replies
1392 Can Donepezil Be Considered a Mild Antipsychotic in
Dementia Treatment? A Report of Donepezil Use in 6 Patients. Takeshi
Terao, Taito Shimomura, and Jun Nakamura
[PDF]
1393 Mania From Dose-Related Ziprasidone Augmentation of an
SSRI. Michael R. Privitera and Kumar Maharaj
[PDF]
1394 Successful Treatment With Clozapine at Higher Doses After
Clozapine-Induced Priapism. Alexander de Nesnera
[PDF]
Book Reviews 1396
NOW @ Psychiatrist.com 1403
Information for authors
see www.psychiatrist.com/author.htm
for complete information